Comparative Efficacy of Tamsulosin Versus Tadalafil As Medical Expulsive Therapy for Distal Ureteric Stones

Overview

Journal Urol Ann

Specialty Urology

Date 2018 Feb 9

PMID 29416281

Citations 2

Authors

Suresh Kumar Goyal

Vikash Singh

Himanshu Pandey

Mahaveer Kumar Chhabra

Satinder Pal Aggarwal

Amilal Bhat

Affiliations

Soon will be listed here.

Abstract

Objective: The objective of this study was to compare the relative efficacy of tamsulosin and tadalafil as medical expulsive therapy for distal ureteric stones.

Patients And Methods: This was a prospective study performed between December 2014 and February 2016. A total of 123 adult patients (>18 years of age) presenting with distal ureteric stones sized 6-10 mm were randomized to treatment with tamsulosin 0.4 mg once daily (Group A) or tadalafil10 mg once daily (Group B). Therapy was given for a maximum of 4 weeks. The stone expulsion rate was the primary endpoint. Time to stone expulsion, number of colic episodes, analgesic use, number of hospital visits for pain, endoscopic treatment, and adverse effects of the drugs were noted. Statistical analyses were done using Fisher's exact test and Chi-square test.

Results: A total of 61 patients were included in tamsulosin group and 62 patients in tadalafil group. A statistically insignificant difference was found for stone clearance rate between both groups as a whole (Group A-73.77%, Group B-69.35%, = 0.690) as well as when we considered both subgroups (A1-78.05%, B1-75.0%, = 0.802; A2-65.0%, B2-55.6%, = 0.741). All the primary and secondary outcome measures were more in favour of stones ≤8 mm size than stones >8 mm size. No statistical difference was found for adverse drug effects except for retrograde ejaculation, which was significantly high in tamsulosin group ( < 0.001).

Conclusion: This study showed that although tamsulosin is more effective for stone clearance than tadalafil, but this difference was not significant ( = 0.690).

Citing Articles

Pooled-analysis of tadalafil and tamsulosin for ureteral calculi.

Sun F, Liu H, Wu G, Liu M, Liu S, Wang L Front Pharmacol. 2024; 15:1351312.

PMID: 38873423 PMC: 11169629. DOI: 10.3389/fphar.2024.1351312.

Tamsulosin vs. Tadalafil as medical expulsive therapy for distal ureteral stones: a systematic review and meta-analysis.

Belkovsky M, Zogaib G, Passerotti C, de Almeida Artifon E, Otoch J, da Cruz J Int Braz J Urol. 2023; 49(6):668-676.

PMID: 37903004 PMC: 10947629. DOI: 10.1590/S1677-5538.IBJU.2023.0345.

References

Tiselius H, Ackermann D, Alken P, Buck C, Conort P, Gallucci M . Guidelines on urolithiasis. Eur Urol. 2001; 40(4):362-71. DOI: 10.1159/000049803. View

Dellabella M, Milanese G, Muzzonigro G . Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol. 2003; 170(6 Pt 1):2202-5. DOI: 10.1097/01.ju.0000096050.22281.a7. View

Segura J, Preminger G, Assimos D, Dretler S, Kahn R, Lingeman J . Ureteral Stones Clinical Guidelines Panel summary report on the management of ureteral calculi. The American Urological Association. J Urol. 1997; 158(5):1915-21. DOI: 10.1016/s0022-5347(01)64173-9. View

Carstensen H, Hansen T . Stones in the ureter. Acta Chir Scand Suppl. 1973; 433:66-71. View

Gratzke C, Uckert S, Kedia G, Reich O, Schlenker B, Seitz M . In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach. Urol Res. 2006; 35(1):49-54. DOI: 10.1007/s00240-006-0073-1. View

Lojanapiwat B, Kochakarn W, Suparatchatpan N, Lertwuttichaikul K . Effectiveness of low-dose and standard-dose tamsulosin in the treatment of distal ureteric stones: a randomized controlled study. J Int Med Res. 2008; 36(3):529-36. DOI: 10.1177/147323000803600318. View

Zhou S, Lu J, Hui J . Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones. World J Urol. 2011; 29(6):767-71. DOI: 10.1007/s00345-011-0739-3. View

Seitz C, Liatsikos E, Porpiglia F, Tiselius H, Zwergel U . Medical therapy to facilitate the passage of stones: what is the evidence?. Eur Urol. 2009; 56(3):455-71. DOI: 10.1016/j.eururo.2009.06.012. View

Al-Ansari A, Al-Naimi A, Alobaidy A, Assadiq K, Azmi M, Shokeir A . Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients. Urology. 2010; 75(1):4-7. DOI: 10.1016/j.urology.2009.09.073. View

10.

Liatsikos E, Katsakiori P, Assimakopoulos K, Voudoukis T, Kallidonis P, Constantinides C . Doxazosin for the management of distal-ureteral stones. J Endourol. 2007; 21(5):538-41. DOI: 10.1089/end.2006.0107. View

11.

Kumar S, Jayant K, Agrawal S, Singh S . Comparative efficacy of tamsulosin versus tamsulosin with tadalafil in combination with prednisolone for the medical expulsive therapy of lower ureteric stones: a randomized trial. Korean J Urol. 2014; 55(3):196-200. PMC: 3956949. DOI: 10.4111/kju.2014.55.3.196. View

12.

Yilmaz E, Batislam E, Basar M, Tuglu D, Ferhat M, Basar H . The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol. 2005; 173(6):2010-2. DOI: 10.1097/01.ju.0000158453.60029.0a. View

13.

Ibrahim A, Shetty S, Awad R, Patel K . Prognostic factors in the conservative treatment of ureteric stones. Br J Urol. 1991; 67(4):358-61. DOI: 10.1111/j.1464-410x.1991.tb15161.x. View

14.

Coll D, Varanelli M, Smith R . Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol. 2002; 178(1):101-3. DOI: 10.2214/ajr.178.1.1780101. View

15.

Pedro R, Hinck B, Hendlin K, Feia K, Canales B, Monga M . Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study. J Urol. 2008; 179(6):2244-7. DOI: 10.1016/j.juro.2008.01.141. View

16.

Agrawal M, Gupta M, Gupta A, Agrawal A, Sarkari A, Lavania P . Prospective randomized trial comparing efficacy of alfuzosin and tamsulosin in management of lower ureteral stones. Urology. 2009; 73(4):706-9. DOI: 10.1016/j.urology.2008.11.013. View

17.

Tsuzaka Y, Matsushima H, Kaneko T, Yamaguchi T, Homma Y . Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients. Int J Urol. 2011; 18(11):792-5. DOI: 10.1111/j.1442-2042.2011.02850.x. View

18.

Kaneko T, Matsushima H, Morimoto H, Tsuzaka Y, Homma Y . Efficacy of low dose tamsulosin in medical expulsive therapy for ureteral stones in Japanese male patients: a randomized controlled study. Int J Urol. 2010; 17(5):462-5. DOI: 10.1111/j.1442-2042.2010.02499.x. View

19.

Shabsigh R, Seftel A, Rosen R, Porst H, Ahuja S, Deeley M . Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction. Urology. 2006; 68(4):689-96. DOI: 10.1016/j.urology.2006.05.009. View

20.

Chau L, Tai D, Fung B, Li J, Fan C, Li M . Medical expulsive therapy using alfuzosin for patient presenting with ureteral stone less than 10mm: a prospective randomized controlled trial. Int J Urol. 2011; 18(7):510-4. DOI: 10.1111/j.1442-2042.2011.02780.x. View